SCHEMBL4852888

SCHEMBL4852888

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3cccc(NCCN(C)C)c3)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 2/20 0.42
KDR P35968 4/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
ATM Q13315 2/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
SYK P43405 3/20 0.40
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
EGFR P00533 1/20 0.39
HCRTR1 O43613 1/20 0.38
MCHR1 Q99705 1/20 0.38
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
KMT2A Q03164 1/20 0.37
RELA Q04206 1/20 0.37
TNFRSF1A P19438 1/20 0.36
KIT P10721 1/20 0.36
FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4847749 0.90 ACHE (0.42) KDRLMNAMAPTATMHTT
SCHEMBL4846060 0.89 MAPT (0.50) KDRLMNAMAPTATMHPGD
SCHEMBL4846042 0.89 MAPT (0.50) KDRLMNAMAPTATMHPGD
SCHEMBL4853345 0.87 RELA (0.48) KDRSYKBCHEACHERELA
SCHEMBL4853514 0.86 NR1H4 (0.47) KDRBCHEACHE
SCHEMBL4853736 0.86 BCHE (0.52) LMNAMAPTBCHEACHEMCHR1
SCHEMBL4856637 0.85 LMNA (0.45) KDRLMNAMAPTATMHPGD
SCHEMBL3689622 0.85 HCRTR2 (0.38) HCRTR2LMNAMAPTATMHPGD
SCHEMBL4846169 0.84 BCHE (0.42) KDRBCHEACHETNFRSF1APTPN1
SCHEMBL4852884 0.83 SYK (0.45) HCRTR2KDRSYKBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed